Polaris International Holdings, Inc. Sets Date to Plant Hemp Seed on Kentucky Farm
01 5월 2014 - 9:15PM
Marketwired
Polaris International Holdings, Inc. Sets Date to Plant Hemp Seed
on Kentucky Farm
PLANO, TX--(Marketwired - May 1, 2014) - Polaris International
Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) has purchased
over 2,000 lbs of hemp seed to plant on the 70 acre farm in
Kentucky. The Company plans on planting the seeds on May 24 and 25,
2014, with the help of several area Military Veterans. This event
should receive significant media coverage throughout the area.
The hemp seed being planted is to be used for the production of
The Company's ProCannas line of products. This will help the
Company with both cost and quality control of hemp being used in
the ProCannas products. Tentative plans for extraction of the CBDs
from the growth production will be completed within Kentucky which
will decrease delivery and production time.
"We are excited to start growing our own brand of hemp products.
We can control the quality and precision of the products coming
from our own fields. This gives us a competitive advantage over our
competitors," states Medical Director, Dr. Vasthi Alvarez
Avila.
ABOUT THE COMPANY
Polaris International Holdings, Inc.'s line ProCannas focuses on
the manufacture and distribution of new, pharmaceutical grade
cannabinoid based products for medicinal use. With the Joint
Venture 70 acre hemp farm in Kentucky, the Company will grow and
develop a large portion of its own hemp products. Due to the
concentrated strength and unique mix of ingredients integrated
within our products, they are intended to be available to patients
only through licensed participating physicians. Due to recent
changes in the law regarding the medical use of marijuana, coupled
with studies and a strong body of evidence highlighting that THC is
not the significant component for medicinal use, doors are opening
for innovation. Laws are expected to become even more favorable for
companies like ProCannas. The Company intends to target a broad
range of specialties with this novel product, including but not
limited to sports medicine, pain management, neurology, and
osteopathic medicine.
Safe Harbor Statement:
This news release includes
forward-looking statements pertaining to future anticipated
projected plans, performance and developments, intended to qualify
for the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Any statements on this
news release that are not statements of historical fact should be
considered forward-looking statements. These forward-looking
statements generally can be identified by phrases such as
"believes," "expects," "anticipates," "foresees," "forecasts,"
"estimates," "intends," or other words or phrases of similar
import. Similarly, statements in this news release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc.
www.Procannas.net Info@Procannas.net
Polaris (CE) (USOTC:PIHN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Polaris (CE) (USOTC:PIHN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024